113 related articles for article (PubMed ID: 37674344)
1. Matrine exerts an anti-tumor effect via regulating HN1 in triple breast cancer both in vitro and in vivo.
Guo Q; Yu Y; Tang W; Zhou S; Lv X
Chem Biol Drug Des; 2023 Dec; 102(6):1469-1477. PubMed ID: 37674344
[TBL] [Abstract][Full Text] [Related]
2. MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway.
Wei S; Zhang Y; Ma X; Yao Y; Zhou Q; Zhang W; Zhou C; Zhuang J
Sci Rep; 2023 Jul; 13(1):12351. PubMed ID: 37524857
[TBL] [Abstract][Full Text] [Related]
3. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
4. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF
Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870
[TBL] [Abstract][Full Text] [Related]
5. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147.
Wang C; Xu C; Niu R; Hu G; Gu Z; Zhuang Z
BMC Cancer; 2019 Jun; 19(1):577. PubMed ID: 31196010
[TBL] [Abstract][Full Text] [Related]
6. Matrine induces apoptosis in multiple colorectal cancer cell lines in vitro and inhibits tumour growth with minimum side effects in vivo via Bcl-2 and caspase-3.
Gu YY; Chen MH; May BH; Liao XZ; Liu JH; Tao LT; Man-Yuen Sze D; Zhang AL; Mo SL
Phytomedicine; 2018 Dec; 51():214-225. PubMed ID: 30466620
[TBL] [Abstract][Full Text] [Related]
7. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
[TBL] [Abstract][Full Text] [Related]
8. Matrine restrains the development of colorectal cancer through regulating the AGRN/Wnt/β-catenin pathway.
Li X; Lu Y; Wen P; Yuan Y; Xiao Z; Shi H; Feng E
Environ Toxicol; 2023 Mar; 38(4):809-819. PubMed ID: 36620879
[TBL] [Abstract][Full Text] [Related]
9. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
[TBL] [Abstract][Full Text] [Related]
10. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
11. Matrine inhibits hepatocellular carcinoma cell malignancy through the circ_0013290/miR-139-5p/MMP16 pathway.
Chang X; Huang Z; Zhang Z; Pan W; Song C
Histol Histopathol; 2023 Oct; 38(10):1179-1192. PubMed ID: 36594718
[TBL] [Abstract][Full Text] [Related]
12. Soyasaponin Ag inhibits triple-negative breast cancer progression via targeting the DUSP6/MAPK signaling.
Huang S; Huang P; Wu H; Wang S; Liu G
Folia Histochem Cytobiol; 2021; 59(4):291-301. PubMed ID: 34970732
[TBL] [Abstract][Full Text] [Related]
13. Matrine induces hepatocellular carcinoma apoptosis and represses EMT and stemness through microRNA-299-3p/PGAM1 axis.
Wang B; Wang H; Zhao Q; Lu F; Yan Z; Zhou F; Su Q
Growth Factors; 2022 Nov; 40(5-6):200-211. PubMed ID: 36260520
[TBL] [Abstract][Full Text] [Related]
14. Matrine Inhibits Proliferation, Invasion, and Migration and Induces Apoptosis of Colorectal Cancer Cells Via miR-10b/PTEN Pathway.
Cheng Y; Yu C; Li W; He Y; Bao Y
Cancer Biother Radiopharm; 2022 Dec; 37(10):871-881. PubMed ID: 32907349
[No Abstract] [Full Text] [Related]
15. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.
Zhou Y; Ma G; Peng S; Tuo M; Li Y; Qin X; Yu Q; Kuang S; Cheng H; Li J
Thorac Cancer; 2021 Sep; 12(18):2427-2438. PubMed ID: 34324278
[TBL] [Abstract][Full Text] [Related]
16. [Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP].
Ou HL; Wu H; Ren YL; Si Y; Duan ZQ; Liu XW
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4483-4492. PubMed ID: 37802875
[TBL] [Abstract][Full Text] [Related]
17. [Matrine suppresses stemness of hepatocellular carcinoma cells by regulating β-catenin signaling pathway].
Dai M; Cai Z; Chen N; Li J; Wen J; Tan L; Guo D
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Oct; 39(10):1239-1245. PubMed ID: 31801708
[TBL] [Abstract][Full Text] [Related]
18. The HN1/HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin.
Wang R; Fu Y; Yao M; Cui X; Zhao Y; Lu X; Li Y; Lin Y; He S
FEBS J; 2022 Oct; 289(20):6400-6419. PubMed ID: 35596723
[TBL] [Abstract][Full Text] [Related]
19. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
[TBL] [Abstract][Full Text] [Related]
20. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
Chen H; Pan H; Qian Y; Zhou W; Liu X
Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
